Apelin-17 (human, bovine)Endogenous APJ receptor agonist CAS# 217082-57-0 |
- LDK378
Catalog No.:BCC3691
CAS No.:1032900-25-6
- LDK378 dihydrochloride
Catalog No.:BCC1694
CAS No.:1380575-43-8
- TAE684 (NVP-TAE684)
Catalog No.:BCC3660
CAS No.:761439-42-3
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 217082-57-0 | SDF | Download SDF |
PubChem ID | 90488791 | Appearance | Powder |
Formula | C96H156N34O20S | M.Wt | 2138.56 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | K17F, Prepro-61-77-Apelin | ||
Solubility | Soluble to 1.20 mg/ml in water | ||
Sequence | KFRRQRPRLSHKGPMPF | ||
SMILES | CC(C)CC(C(=O)NC(CO)C(=O)NC(CC1=CNC=N1)C(=O)NC(CCCCN)C(=O)NCC(=O)N2CCCC2C(=O)NC(CCSC)C(=O)N3CCCC3C(=O)NC(CC4=CC=CC=C4)C(=O)O)NC(=O)C(CCCNC(=N)N)NC(=O)C5CCCN5C(=O)C(CCCNC(=N)N)NC(=O)C(CCC(=O)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CCCNC(=N)N)NC(=O)C(CC6=CC=CC=C6)NC(=O)C(CCCCN)N | ||
Standard InChIKey | SVWSKJCJNAIKNH-MJZUAXFLSA-N | ||
Standard InChI | InChI=1S/C96H156N34O20S/c1-55(2)47-67(83(140)127-71(53-131)86(143)125-69(50-58-51-109-54-115-58)85(142)116-60(26-11-13-38-98)78(135)114-52-76(133)128-43-18-31-72(128)87(144)122-66(36-46-151-3)91(148)130-45-20-33-74(130)89(146)126-70(92(149)150)49-57-23-8-5-9-24-57)124-81(138)63(29-16-41-112-95(105)106)120-88(145)73-32-19-44-129(73)90(147)65(30-17-42-113-96(107)108)121-82(139)64(34-35-75(100)132)119-80(137)61(27-14-39-110-93(101)102)117-79(136)62(28-15-40-111-94(103)104)118-84(141)68(48-56-21-6-4-7-22-56)123-77(134)59(99)25-10-12-37-97/h4-9,21-24,51,54-55,59-74,131H,10-20,25-50,52-53,97-99H2,1-3H3,(H2,100,132)(H,109,115)(H,114,135)(H,116,142)(H,117,136)(H,118,141)(H,119,137)(H,120,145)(H,121,139)(H,122,144)(H,123,134)(H,124,138)(H,125,143)(H,126,146)(H,127,140)(H,149,150)(H4,101,102,110)(H4,103,104,111)(H4,105,106,112)(H4,107,108,113)/t59-,60-,61-,62-,63-,64-,65-,66-,67-,68-,69-,70-,71-,72-,73-,74-/m0/s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Endogenous apelin receptor agonist. Potently inhibits forskolin-stimulated cAMP accumulation (pIC50 = 9.94). |
Apelin-17 (human, bovine) Dilution Calculator
Apelin-17 (human, bovine) Molarity Calculator
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- WB 4101 hydrochloride
Catalog No.:BCC6858
CAS No.:2170-58-3
- 15-Epi-Danshenol-A
Catalog No.:BCN3146
CAS No.:216987-13-2
- Shyobunone
Catalog No.:BCN4930
CAS No.:21698-44-2
- Procurcumenol
Catalog No.:BCN3555
CAS No.:21698-40-8
- Z-DL-Nva-OH
Catalog No.:BCC3304
CAS No.:21691-44-1
- Z-N-Me-Ala-OH
Catalog No.:BCC3344
CAS No.:21691-41-8
- Lauroscholtzine
Catalog No.:BCN4929
CAS No.:2169-44-0
- Kulinone
Catalog No.:BCN7954
CAS No.:21688-61-9
- Fludarabine
Catalog No.:BCC2518
CAS No.:21679-14-1
- Shoreic acid
Catalog No.:BCN4928
CAS No.:21671-00-1
- Bisphenol P
Catalog No.:BCC8891
CAS No.:2167-51-3
- Sophoflavescenol
Catalog No.:BCN2891
CAS No.:216450-65-6
- [Pyr1]-Apelin-13
Catalog No.:BCC7358
CAS No.:217082-60-5
- Esomeprazole Magnesium trihydrate
Catalog No.:BCC1559
CAS No.:217087-09-7
- Hugorosenone
Catalog No.:BCN3776
CAS No.:217096-49-6
- BCX 1470
Catalog No.:BCC1413
CAS No.:217099-43-9
- BCX 1470 methanesulfonate
Catalog No.:BCC1414
CAS No.:217099-44-0
- Etifoxine
Catalog No.:BCC1560
CAS No.:21715-46-8
- PD 173212
Catalog No.:BCC7706
CAS No.:217171-01-2
- Aristoliukine B
Catalog No.:BCN8096
CAS No.:217310-32-2
- Spectinomycin dihydrochloride
Catalog No.:BCC5166
CAS No.:21736-83-4
- 5-O-Demethylnobiletin
Catalog No.:BCN2958
CAS No.:2174-59-6
- 5-Methoxyresorcinol
Catalog No.:BCN6904
CAS No.:2174-64-3
- SB 268262
Catalog No.:BCC7916
CAS No.:217438-17-0
Pharmacological and immunohistochemical characterization of the APJ receptor and its endogenous ligand apelin.[Pubmed:12603839]
J Neurochem. 2003 Mar;84(5):1162-72.
Apelin peptides have recently been identified to be the endogenous ligands for the G protein-coupled receptor APJ. However, little is known about the physiological roles of this ligand-receptor pairing. In the present study we investigated the pharmacology of several apelin analogues at the human recombinant APJ receptor using radioligand binding and functional assays. This has led to the identification of key residues in the apelin peptide required for functional potency and binding affinity through structure-activity studies. In particular, we have identified that replacement of leucine in position 5, or arginine in position 2 and 4 of the C-terminal apelin peptide, apelin-13, resulted in significant changes in pharmacology. We also investigated the detailed localization of pre-proapelin and APJ receptor mRNA in a wide range of human, rat and mouse tissues using quantitative RT-PCR, and carried out a detailed immunohistochemical study of the distribution of the APJ receptor in rat brain and spinal cord. Interestingly, the APJ receptor was not only co-localized in white matter with GFAP in the spinal cord, but was also clearly localized on neurones in the brain, suggesting that this receptor and its peptide may be involved in a wide range of biological process yet to be determined.